Marcel Salathé, an assistant professor of biology, studied how users of Twitter -- a popular microblogging and social-networking service -- expressed their sentiments about a new vaccine. He then tracked how the users' attitudes correlated with vaccination rates and how microbloggers with the same negative or positive feelings seemed to influence others in their social circles.
The research is considered the first case study in how social-media sites affect and reflect disease networks, and the method is expected to be repeated in the study of other diseases. The results will be published in the journal PLoS Computational Biology.
Salathé explained that he chose Twitter for two reasons. First, unlike the contents of Facebook, Twitter messages, known as "tweets," are considered public data and anyone can "follow," or track, the tweets of anyone else. "People tweet because they want other members of the public to hear what they have to say," Salathé said. Second, Twitter is the perfect database for learning about people's sentiments. "Tweets are very short -- a maximum of 140 characters," Salathé explained. "So users have to express their opinions and beliefs about a particular subject very concisely." Salathé began by amassing 477,768 tweets with vaccination-related keywords and phrases. He then tracked users' sentiments about a particular new vaccine for combating H1N1 -- a virus strain responsible for swine flu. The collection process began in August 2009, when news of the new vaccine first was made public, and continued through January 2010.
Salathé explained that sorting through the enormous number of vaccination-related tweets was no simple matter. First, he partitioned a random subset of about 10 percent and asked Penn State students to rate them as positive, negative, neutral, or irrelevant. For example, a tweet expressing a desire to get the H1N1 vaccine would be considered positive, while a tweet expressing the belief that the vaccine causes harm would be considered negative. A tweet concerning a different vaccine, for example, the Hepatitis B vaccine, would be considered irrelevant. Then, Shashank Khandelwal, a computer programmer and analyst in Penn State's Department of Biology and co-author of the paper, used the students' ratings to design a computer algorithm responsible for cataloging the remaining 90 percent of the tweets according to the sentiments they expressed. "The human-rated tweets served as a 'learning set' that we used to 'teach' the computer how to rate the tweets accurately," Salathé explained. After the tweets were analyzed by the computer algorithm, the final tally, after the irrelevant ones were eliminated, was 318,379 tweets expressing either positive, negative, or neutral sentiments about the H1N1 vaccine.
Because Twitter users often include a location in their profiles, Salathé was able to categorize the expressed sentiments by U.S. region. Also, using data from the Centers for Disease Control and Prevention (CDC), he was able to determine how vaccination attitudes correlated with CDC- estimated vaccination rates. Using these data, Salathé found definite patterns. For example, the highest positive-sentiment users were from New England, and that region also had the highest H1N1 vaccination rate. "These results could be used strategically to develop public-health initiatives," Salathé explained. "For example, targeted campaigns could be designed according to which region needs more prevention education. Such data also could be used to predict how many doses of a vaccine will be required in a particular area."
In addition, Salathé was able to construct an intricate social network by determining who followed the tweets of whom; that is, he was able to determine clusters of like-minded Twitter users. "The assumption is that people tend to communicate online almost exclusively with people who think the same way. This phenomenon creates 'echo chambers' in which dissenting opinions are not heard," Salathé said. As it turned out, that assumption was correct. Salathé found that users with either negative or positive sentiments about the H1N1 vaccine followed like-minded people. "The public-health message here is obvious," Salathé said. "If anti-vaccination communities cluster in real, geographical space, as well, then this is likely to lead to under-vaccinated communities that are at great risk of local outbreaks." He explained that, when unvaccinated individuals cluster together, herd immunity -- a population-level immunity that occurs when a critical mass has been vaccinated -- no longer affords much protection against disease. "By definition, herd immunity only works if unvaccinated, unprotected individuals are distributed sparsely throughout the population, buffered from the disease by vaccinated individuals," Salathé said. "Unfortunately, the data from Twitter seem to indicate that the buffer of protection cannot be counted on if these clusters exist in real, geographical space."
In addition to location-related and network patterns, Salathé was able to track sentiment patterns over time. For example, he found that negative expressions spiked during the time period when the vaccine was first announced. Later, more-positive sentiments emerged when the vaccine was first shipped across the United States. Salathé also tracked spikes of negative tweets that corresponded, not surprisingly, to periods of vaccine recall.
Salathé plans to use his unique social-media analysis to study other diseases, such as obesity, hypertension, and heart disease. "We think of a disease such as obesity as noninfectious, while a disease such as the flu is clearly infectious. However, it might be more useful to think of behavior-influenced diseases as infectious, as well," Salathé said. "Lifestyle choices might be 'picked up' in much the same way that pathogens -- viruses or bacteria -- are acquired. The difference is simply that in the one instance the infectious agent is an idea rather than a biological entity."
Salathé added that, in the industrialized world, future generations will worry less about infectious diseases and more about diseases linked to lifestyle and behavior. "Behavior-influenced diseases always have existed, but, until recently, they were masked: People died of infectious diseases relatively early in their life cycles. So behavior-influenced diseases weren't really on anyone's radar," Salathé explained. "Now that heart disease -- a malady caused, at least in part, by lifestyle -- is moving to the top of the list of killers, it might be wise to focus on how social media influences behaviors such as poor diet and infrequent exercise," Salathé said.
The research was funded by a Society in Science-Branco Weiss Fellowship.
Marcel Salathé: (+1) 408-386-8916, firstname.lastname@example.org
Barbara Kennedy (PIO): (+1) 814-863-4682, email@example.com
High-resolution images associated with this research are online at http://http://science.psu.edu/news-and-events/2011-news/Salathe10-2011Caption: Marcel Salathé used Twitter data to track vaccination rates and sentiments.
Credit: U.S. National Institutes of Health
Barbara Kennedy | EurekAlert!
How to design city streets more fairly
18.05.2020 | Mercator Research Institute on Global Commons and Climate Change (MCC) gGmbH
Insects: Largest study to date confirms declines on land, but finds recoveries in freshwater – Highly variable trends
24.04.2020 | Deutsches Zentrum für integrative Biodiversitätsforschung (iDiv) Halle-Jena-Leipzig
In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".
Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...
Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.
researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...
Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.
When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...
Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.
Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...
Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.
A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...
19.05.2020 | Event News
07.04.2020 | Event News
06.04.2020 | Event News
29.05.2020 | Materials Sciences
29.05.2020 | Materials Sciences
29.05.2020 | Power and Electrical Engineering